Introduction
Despite declining incidence of obstructive coronary artery disease (CAD), angina pectoris is very common, reaching an overall prevalence in the Europe of 6.7%. 1 The use of both non-invasive and invasive diagnostic tests in the assessment of suspected stable CAD has increased considerably over the last decades. This may be beneficial for some but may also expose others to risk and be the cause of resource expenditure without benefit. Registry data of patients referred to invasive angiography indicate a low diagnostic yield and have questioned the value of non-invasive testing, particularly in women. [2] [3] [4] In the recent PROMISE trial of patients with angina referred for non-invasive diagnostic workup, among women less than 3% ultimately required revascularization. 5, 6 This proportion is much lower than the proportion expected from pretest probability (PTP) in current guidelines for the diagnostic workup for stable CAD. 7 In addition, patients with stable angina appear to have a good prognosis. 8, 9 The reality of a declining prevalence of obstructive CAD and a good prognosis questions resource demanding approach recommended in current guidelines. This study, representing current clinical out-patient hospital practice, aimed to describe the diagnostic workup among patients suspected of stable CAD and to explore whether a more rational and cost-effective approach can be outlined.
Methods

Study population
The study is a retrospective observational cohort study of patients without previously diagnosed CAD referred in 2012-15 for specialist assessment of suspected stable CAD. All patients referred to non-invasive or invasive testing in a single, large, urban university hospital with a catchment population of >400 000 inhabitants, were assessed for eligibility ( Figure 1 ). Patients were eligible if they were referred with chest pain suspected to be angina pectoris or dyspnoea on exertion as an angina equivalent, had their medical history taken by a cardiologist, and had received at least one diagnostic test with the purpose of detecting CAD. Information on primary presenting symptoms, i.e. angina typicality, cardiovascular risk factors, results of non-invasive tests (NIT), and invasive coronary angiography (ICA) was gathered from registries and individual patient records at baseline. Baseline was defined as the date of the patient's first visit of investigation at the hospital. Patients suspected of acute coronary syndrome, with known CAD, including a history of myocardial infarction, percutaneous intervention, coronary bypass surgery, or missing information were excluded ( Figure 1 ).
Data sources
Data were extracted from individual patient records of all patients in the catchment area booked for a diagnostic NIT or referred directly to ICA. Data on angiography were derived from a clinical registry of invasive procedures, Web-Pats, which covers all invasive cardiac procedures performed in the Capital Region and the Region of Zealand since 2009. Data elements included patient characteristics, risk factors, procedural findings, and interventions. All data were safely stored and handled according to Danish data regulations.
Definitions
Non-invasive test included exercise electrocardiogram (ECG), stress echocardiography, myocardial perfusion imaging (MPI), and coronary computed tomographic angiography (CCTA). Test outcomes were defined as negative, positive, or inconclusive. An exercise ECG was defined as positive by the attending physician if significant ST-depression developed or if the test was terminated due to reproduction of symptoms. 7 Myocardial perfusion imaging was defined as positive if reversible ischaemia in the myocardium was present. Patients with MPI with <10% reversible ischaemia who were not referred to invasive angiography but treated with optimal medical treatment were excluded from the analyses (n = 99). Stress echocardiography positivity required evidence of new myocardial hypokinesis during exercise or dobutamine stress. Positivity on CCTA was defined as > _50% stenosis in any epicardial vessel. Obstructive CAD was defined from invasive angiography as a lesion either requiring revascularization, >70% stenosis of any epicardial vessel or 50-70% stenosis with fractional flow reserve (FFR) <0.8.
7
European guidelines recommend an assessment of the angina typicality and a PTP score in the management of stable angina prior to a diagnostic strategy. 7 Angina classification followed the traditional clinical classification according to guidelines as typical, atypical, or non-angina pain from the description of patient symptoms at baseline. Typical angina was defined as having (i) substernal chest pain or discomfort that is (ii) provoked by exertion or emotional stress and (iii) relieved by rest and/or nitroglycerine. Atypical angina was defined as fulfiling two of these criteria. If only one or none of the criteria was present, the patient was classified as having non-angina pain. 7 The Diamond and Forrester classification modified by Genders et al. 10 was used to determine PTP for obstructive CAD using age, sex, and angina typicality. 11 ESC guidelines recommend direct referral to invasive angiography if PTP is >85%, non-invasive testing for PTP 15-85% and no testing for PTP <15%.
Statistical analysis
The two genders differed in symptom presentation, PTP, and diagnostic yield and were analysed separately. tested in the model and retained if P < 0.05. The predictive ability of each covariate was compared in men and women by including interaction terms with sex in a combined model. The area under the receiver-operating curve (AUC) was used to assess the discriminatory capacity for each gender separately. All statistical analyses were conducted with STATA version 13.
Results
Baseline characteristics
After screening 15 798 patient records, 4028 patients were included in the study (Figure 1 ), 2209 (55%) women and 1819 (45%) men. The mean age of the population was 58 years (interquartile range 49-68) with women being 2.7 years older than men (P = 0.001) ( Table 1) .
Overall, gender differences in risk factor distribution were minor although in some cases reached statistical significance: men were more likely to have diabetes, be smokers, and be overweight while women were more likely to have a family history of CAD.
In both the sexes, the majority (>85%) presented with chest pain as primary symptom while the remaining reported dyspnoea on exertion. Women were more likely to have non-angina chest pain (60.2 vs. 54.5%) and less likely to have typical angina (8.2 vs. 11.8%, P < 0.001). The mean PTP for obstructive CAD according to the modified Diamond and Forrester risk score 10 was 20.9% in women and 45.1% in men (P < 0.001). Correspondingly, 36.8% of the women had a low (<15%) PTP while 97.3% of the men had an intermediate (15-85%) PTP. Only 1.2% of all patients had a high (>85%) PTP.
Initial testing
A total of 93% of patients (n = 3744) underwent at least one NIT while 7% (n = 284) were referred directly to ICA ( Figure 1 , Table 1 ).
Myocardial perfusion imaging and CCTA were the most used NIT modalities comprising 75%. Characteristics of populations referred to each NIT modality are shown in Table 2 . Patients referred to MPI were older and had higher PTP whereas patients referred to CCTA had lower PTP. In all, 5.5% of women and 8.9% of men were referred directly to ICA: After adjusting for age, angina typicality and risk factors, men remained more likely to be referred directly to ICA [odds ratio (OR) 1.42 (1.07-1.88)].
Non-invasive test results
Overall, 6.9% of NIT's were inconclusive with no gender difference in any of the test modalities ( Figure 2 ). Women were less likely to have a positive NIT result (5.2 vs. 8.7%, P < 0.001). Distribution of positive NIT by gender, age, and symptoms according to the modified Diamond Forrester algorithm 7, 12 is shown in Table 3 . As expected, the proportion of positive NIT was higher in patients with typical and atypical angina. The highest proportion of positive tests was seen in men above age 60 with typical and atypical angina reaching 24-30%. Among the 1238 men and 1595 women (70% of all patients) with non-angina pain or dyspnoea as primary symptom, the probability of a positive NIT was 6.1% and 2.9%, respectively (range 1-15%). Figure 3 gives the proportion of NIT that was positive by gender and age. Men aged greater than 50 years were twice as likely to have a positive test while those younger than 50 years had no gender difference. In an attempt to identify patients who will benefit from noninvasive testing, we performed sex-specific logistic regression. In univariate logistic regression analyses age, angina typicality and most cardiovascular risk factors were predictive of a positive NIT result in both sexes ( Table 4) . In multivariate models only age, symptoms, and dyslipidaemia remained significant predictors of a positive NIT with little difference in ORs between men and women. The AUC of the multivariable model was similar for women 0.77 (0.72-0.82) and men 0.77 (0.74-0.80) (Figure 4) .
In a model combining men and women, the only significant interaction with sex was seen for age confirming the crude finding depicted in Figure 3 : OR of having a positive NIT for men aged greater than 50 years compared with women was 2.36 (1.79-3.12), whereas OR for men aged younger than 50 years was 0.78 (0.33-1.88) (P for 
Invasive angiography results
With the exception of 14 patients, all patients with a positive NIT (n = 259) underwent invasive angiography. A total of 105/259 (40.5%) of these patients had obstructive CAD on angiography with no differences between the four test modalities (P = 0.40). Women were less likely to have obstructive CAD: 27 (23.8%) of the women with a positive NIT and 78 (49.1%) of the men had obstructive CAD (P for gender difference <0.001). After age-adjustment, the malefemale OR of obstructive CAD among patients with positive NIT was 3.33 (1.93-5.73). For comparison, findings among the 284 patients referred directly to angiography with no preceding NIT, the proportion with obstructive CAD was similar: 20.5% in women and 48.5% in men (P for gender difference <0.001) and the age-adjusted male-female OR was 3.89 (2.25-6.73). Overall, 259 (6.4%) of all referred patients were diagnosed with obstructive CAD.
Discussion
The objective of this study was to describe the diagnostic workup among patients suspected of stable CAD referred for specialist assessment and explore whether the diagnostic approach and resource In recent decades the proportion of patients with angina undergoing invasive angiography found to have obstructive CAD has declined and is particularly low in women. 2, 3 This low diagnostic yield has led to discussions of overuse of invasive assessment because of the associated costs and the rare but potentially serious complications. 13 Large registry studies have questioned the diagnostic preangiographic workup pointing to poor predictive abilities of symptoms and non-invasive tests. However, these studies are based on the highly selected subgroup of angina patients referred to invasive angiography 2, 3 and are likely to give a biased and incomplete view of the diagnostic pathway from referral to final diagnosis. The recent PROMISE trial 13 has addressed gender differences in preangiographic diagnostic workup, but suffer from selection bias as the mean number of patients included per year was only 17 in each of the 193 sites, in contrast to the >1000 patients included per year at our centre. Thus, the data presented in this article represent contemporary clinical practice focusing on the entire population of patients presenting to a cardiologic department with suspected stable CAD. Accordingly, the present study provides unique information about clinical presentation, evaluation, and testing results and may serve as Values are number (%). Distribution of positive non-invasive test by sex, age, and symptoms among 3744 patients suspected of stable angina referred for non-invasive diagnostic assessment. For age-and gender-defined categories with less than 10 patients no values are given. Colour of boxes according to ESC modified PTP. Groups in red boxes: PTP > 85%; groups in light red boxes: PTP 66-85%; groups in blue boxes: PTP 15-65%; groups in white boxes: PTP < 15%, green boxes: not PTP classified. highly relevant data input for development of a rational diagnostic workup in a modern clinical care. Previous studies have indicated men being more likely to present with typical symptoms. 14, 15 We found that only 8.2% of women and 11.8% of men had typical angina, thus in both men and women the large majority of patients presented with either atypical angina or non-angina symptoms. The proportion with atypical angina in this study was low in comparison with other studies (18% vs. 78% in the PROMISE trial). 13 This might be due to a high selection in the PROMISE study or because of a strict application of angina typicality in our study. When combining atypical angina and non-angina chest pain in one group, 78.6% of women and 73.9% of men had atypical symptoms, which is similar to the finding in the PROMISE trial. 13 Only a minority of our population presented with dyspnoea on exertion (13%) which is in line with previous findings. 16 The mean PTP of CAD according to the modified Diamond and Forrester algorithm 11 was 20.9% in women and 45.1% in men vs.
28.3% and 54.5% in the PROMISE trial. 13 The lower PTP in our study may be because we had no lower age-limit for inclusion. In all, 36.8% of the women had a PTP of <15% and should according to current guidelines not be assessed further; however, we believe that the data reflect current practice with increasingly lower threshold to use a non-invasive or invasive diagnostic test when a patient has been referred for specialist evaluation. In agreement with previous studies, 17, 18 men were twice as likely to be referred directly to invasive angiography even after adjusting for PTP. We found a mean PTP of 21% in women vs. only 3.1% with obstructive CAD and a mean PTP of 45% in men vs. only 10.4% with obstructive CAD. As illustrated in Table 3 , the post-test probability of a positive NIT across all sex, age, and angina typicality groups is much lower than would be expected from the PTP according to the modified Diamond-Forrester algorithm. 7, 12 Added to this, only 23.8% of women and 49.1% of men with a positive NIT had obstructive CAD. Thus, even the modified Diamond-Forrester calculation of PTP of obstructive CAD vastly overestimates the likelihood of obstructive CAD. [19] [20] [21] Similar discrepancy was seen in the PROMISE trial 13 highlighting the need for both better predictive tools and for a diagnostic set-up that takes into account the low probability of obstructive CAD. Symptoms were highly predictive of a positive NIT in both men and women and the model combining symptoms, age and dyslipidaemia performed reasonably well in both men and women. Among patients presenting with non-angina pain and dyspnoea the proportion with positive NIT was particularly low. Notably, the 2016 NICE guidelines recommend routine testing only in patients with typical and atypical angina and in patients with non-angina chest pain with EKG changes. 22 Among patients with non-angina chest pain, the highest proportion of positive test in any subgroup was 10%, indicating that very few cases of obstructive CAD are likely to be overlooked by applying the NICE guidelines. In addition to the low probability of obstructive CAD among patient with suspected, stable angina, these patients in general are considered as a low-risk population with a good prognosis. The recent outcomes-based, randomized trials comparing the use of CTA with stress testing or standard care for the diagnosis of stable CAD, the PROMISE, 6 and the SCOT-HEART trial 9 had cardiovascular event rate of only 1-2% per year. The Euro Heart Survey also found a low annual incidence of death and non-fatal myocardial infarction of only 1.5%. 23 Also annual mortality from clinical trials of secondary prevention, antianginal treatment or revascularization range from 0.9% to 1.7%. [24] [25] [26] In the light of both the good prognosis and the low probability of obstructive CAD in the stable angina population a focus on a more conservative approach is called for, suggesting that either a more simple and resource sparing initial testing, a deferred testing strategy or simply watchful waiting in the diagnostic workup may be appropriate and beneficial, perhaps in particular in women.
Study limitations and strengths
This is a retrospective study, and we had to rely on registration of symptoms and risk factors as assessed by the attending physician. However, symptoms were recorded before the tests were performed, limiting the likelihood of reporting bias. Our cohort differs from the overall primary care angina population, and represents the subset of patients referred for cardiologic assessment. Despite this fact, even this patient group has a low PTP and a very low final diagnosis of obstructive CAD. The greatest strength of the study therefore is the inclusion of a population which is by far much less selected than those both in randomized trials and those in angiographic registries. Therefore, we consider that the current study represents current clinical practice in the management of patients with suspected CAD.
Conclusions
The use of both non-invasive and invasive diagnostic tests in the assessment of suspected stable CAD has increased considerably over the last decades. This may be beneficial for some but may also expose others to radiation risk, unnecessary invasive assessment and be associated with excessive costs. This study confirms that in contemporary clinical practice the prevalence of significant CAD is low among patients referred for assessment, and particularly low among women and among the majority of patients who do not present with typical symptoms. In accordance with the data presented, we suggest a more conservative diagnostic workup is called for with a deferred testing strategy or simply watchful waiting.
